Living Cell Technologies Ltd. in Strong Cash Position to Accelerate Clinical Trial Program

MELBOURNE, AUSTRALIA and AUCKLAND, NEW ZEALAND--(Marketwire - January 30, 2008) - Living Cell Technologies Limited (ASX: LCT) (PINKSHEETS: LVCLY) today announced that the cash balance at the end of the quarter to 31st December 2007 was A$7,643,560, compared to A$1,246,366 at the end of the quarter to September 30th 2007. Operational cash flow at (A$1,388,660) was maintained at a comparable level to the (A$1,164,925) spent in the preceding quarter.
MORE ON THIS TOPIC